enkephalin, leucine has been researched along with n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aloyo, VJ | 1 |
Bar-Shavit, Z; Benzakine, S; Krichevsky, A; Polakiewicz, RD; Rosen, H | 1 |
2 other study(ies) available for enkephalin, leucine and n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
Article | Year |
---|---|
Modulation of mu opioid binding by protein kinase inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analgesics; Animals; Binding, Competitive; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Isoquinolines; Kinetics; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Rabbits; Receptors, Opioid, mu; Sulfonamides; Tritium | 1995 |
Developmental regulation of proenkephalin gene expression in osteoblasts.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Amino Acid Sequence; Animals; Base Sequence; Calcitriol; Cell Differentiation; Cells, Cultured; Enkephalins; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Isoquinolines; Molecular Sequence Data; Osteoblasts; Protein Precursors; Protein Serine-Threonine Kinases; Rats; RNA, Messenger; Signal Transduction; Skull; Transforming Growth Factor beta | 1995 |